Exodrug

Exodrug is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and advanced drug delivery systems. The company utilizes its proprietary Exo-Platform to engineer exosomes for the targeted delivery of therapeutic payloads, aiming to address chronic and intractable diseases with high unmet medical needs. Its primary research focus includes fibrotic diseases such as non-alcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis, as well as regenerative medicine for hair loss and oncology. By leveraging the natural biocompatibility and tissue-specific targeting of exosomes, Exodrug seeks to enhance the efficacy and safety profiles of traditional drug modalities.